Ceribell

CBLLNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$1.010 B

$26.00 -5.08%

Close of 6 Nov 2026

As of 6 Nov 2026, Ceribell (CBLL) has a market capitalization of $1.01B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$89.1M

#2523 by revenue

Earnings

-$53.4M

Loss-making

Shares outstanding

38,835,010

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 26 →

#5TransMedics GroupTMDX$2.40B
#6CONMEDCNMD$1.57B
#7CeribellCBLL$1.01B
#8InModeINMD$769.4M
#9CapsoVisionCV$332.2M

What if Ceribell were worth as much as…

Open the what-if tool →

Gold $28.2T

$727,098.41

Per share 27,965× higher

Bitcoin $1.53T

$39,342.03

Per share 1,513× higher

Apple $5.02T

$129,156.21

Per share 4,968× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Ceribell are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.